cefminox has been researched along with Bacteroides Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, J; Coronel, P; Del Prado, G; Gimeno, M; Gracia, M; Huelves, L; Martínez-Marín, C; Ponte, C; Rodríguez-Cerrato, V; Soriano, F | 1 |
| Date, H; Goi, H; Hara, T; Ishii, T; Jinzaki, M; Kasai, T; Matsugami, A; Miyauchi, K; Shindo, H; Watanabe, T | 1 |
| Goto, S; Hara, T; Inouye, S; Kasai, T; Kazuno, Y; Kuwahara, S; Tamura, A | 1 |
3 other study(ies) available for cefminox and Bacteroides Infections
| Article | Year |
|---|---|
Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
Topics: Abdominal Abscess; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cephamycins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Mice; Sepsis; Treatment Outcome | 2006 |
[Antibacterial activity of MT-141 against anaerobic bacteria].
Topics: Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cephamycins; Clostridium Infections; Clostridium perfringens; Drug Resistance, Microbial; Mice; Moxalactam | 1984 |
In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Drug Stability; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1985 |